Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2021
  2. E-pub ahead of print
  3. Published

    Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study

    Kronborg, T. M., Ytting, H., Hobolth, L., Møller, S. & Kimer, N., 23 Sep 2021, In: Frontiers in Medicine. 8, 718896.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms

    Møller, S., Kimer, N., Kronborg, T., Grandt, J., Hove, J. D., Barløse, M. & Gluud, L. L., Aug 2021, In: Seminars in Liver Disease. 41, 3, p. 235-247 13 p.

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published
  6. Published

    Fecal microbiota transplantation in hepatic encephalopathy: a systematic review

    Madsen, M., Kimer, N., Bendtsen, F. & Petersen, A. M., May 2021, In: Scandinavian Journal of Gastroenterology. 56, 5, p. 560-569 10 p.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019

    Attauabi, M., Burisch, J., Bendtsen, F. & Kimer, N., Apr 2021, In: Scandinavian Journal of Gastroenterology. 56, 4, p. 453-457 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Editorial: non-selective beta blockers-in and out of circulation

    Kimer, N., Mortensen, C. & Hobolth, L., Mar 2021, In: Alimentary Pharmacology and Therapeutics. 53, 5, p. 632-633 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  9. Published

    Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation

    Monteiro, S., Grandt, J., Uschner, F. E., Kimer, N., Madsen, J. L., Schierwagen, R., Klein, S., Welsch, C., Schäfer, L., Jansen, C., Claria, J., Alcaraz-Quiles, J., Arroyo, V., Moreau, R., Fernandez, J., Bendtsen, F., Mehta, G., Gluud, L. L., Møller, S., Praktiknjo, M. & Trebicka, J., Feb 2021, In: Gut. 70, 2, p. 379-387 9 p., 320170.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published
  11. 2020
  12. Published

    Statins for cirrhosis: almost ready for clinical application

    Kimer, N., Kronborg, T. M., Bendtsen, F. & Møller, S., 30 Dec 2020, In: Digestive Medicine Research. 3

    Research output: Contribution to journalComment/debateResearchpeer-review

  13. Published
  14. Published

    Experience from a COVID-19 first-line referral clinic in Greater Copenhagen

    Kronborg, T. M., Kimer, N., Junker, A. E., Werge, M. P., Gluud, L. L. & Ytting, H., 7 Aug 2020, In: Danish Medical Journal. 67, 9

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure

    Praktiknjo, M., Monteiro, S., Grandt, J., Kimer, N., Madsen, J. L., Werge, M. P., William, P., Brol, M., Turco, L., Schierwagen, R., Chang, J., Klein, S., Uschner, F. E., Welsch, C., Moreau, R., Schepis, F., Bendtsen, F., Gluud, L. L., Møller, S. & Trebicka, J., Jun 2020, In: Liver international : official journal of the International Association for the Study of the Liver. 40, 6, p. 1457-1466 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Pathophysiological-based treatments of complications of cirrhosis

    Møller, S., Kimer, N., Barløse, M. & Bendtsen, F., 2 Apr 2020, In: Scandinavian Journal of Gastroenterology. 55, 4, p. 383-394 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  17. Published
  18. Published

    Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial

    Kimer, N., Grønbæk, H., Fred, R. G., Hansen, T., Deshmukh, A. S., Mann, M. & Bendtsen, F., 23 Jan 2020, In: BMJ Open. 10, 1, e035284.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Rifaximin for people with hepatic encephalopathy

    Kimer, N., Krag, A., Bendtsen, F., Møller, S. & Gluud, L. L., 2020, Cochrane Library.

    Research output: Other contributionNet publication - Internet publicationResearchpeer-review

  20. 2018
  21. Published

    No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial

    Kimer, N., Gudmann, N. S., Pedersen, J. S., Møller, S., Nielsen, M. J., Leeming, D. J., Karsdal, M. A., Møller, H. J., Bendtsen, F. & Grønbæk, H., 5 Sep 2018, In: PLoS One. 13, 9

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients

    Riedel, A. N., Kimer, N., Jensen, A-S. H., Dahl, E. K., Israelsen, M., Aamann, L. & Gluud, L. L., 1 May 2018, In: World Journal of Gastroenterology. 24, 15, p. 1650-1657

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Prognosis of patients with ascites after PleurX insertion: an observational study

    Riedel, A. N., Kimer, N., Hobolth, L. & Gluud, L. L., Mar 2018, In: Scandinavian Journal of Gastroenterology. 53, 3, p. 340-344

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published
  25. Published

    Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial

    Kimer, N., Pedersen, J. S., Tavenier, J., Christensen, J. E., Busk, T. M., Hobolth, L., Krag, A., Al-Soud, W. A., Mortensen, M. S., Sørensen, S. J., Møller, S., Bendtsen, F. & And members of the CoRif study group, Jan 2018, In: Journal of Gastroenterology and Hepatology (Australia). 33, 1, p. 307-314

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. 2017
  27. Published

    The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort

    Pedersen, J. S., Kimer, N., Henriksen, J. H., Bendtsen, F. & Møller, S., 1 Oct 2017, In: Hepatology (Baltimore, Md.). 66, 4, p. 1360-1361

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Rifaximin has no effect on hemodynamics in decompensated cirrhosis - A randomized, double blind, placebo controlled trial

    Kimer, N., Pedersen, J. S., Busk, T. M., Gluud, L. L., Hobolth, L., Krag, A., Møller, S., Bendtsen, F. & and the members of the Copenhagen Rifaximin (CoRif) study group., Feb 2017, In: Hepatology (Baltimore, Md.). 65, 2, p. 592-603

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. 2016
  30. Published

    Advances in the treatment of portal hypertension in cirrhosis

    Kimer, N., Wiese, S. S., Mo, S., Møller, S. & Bendtsen, F., Jul 2016, In: Expert review of gastroenterology & hepatology. 10, 8, p. 961-969 9 p.

    Research output: Contribution to journalReviewResearchpeer-review

  31. Published
  32. 2015
  33. Published

    Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature

    Kimer, N., Feineis, M., Møller, S. & Bendtsen, F., 2015, In: Scandinavian Journal of Gastroenterology. 50, p. 129-139

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Intervention protocol: Rifaximin for people with hepatic encephalopathy

    Kimer, N., Krag, A., Møller, S. & Gluud, L. L., 2015

    Research output: Other contributionNet publication - Internet publicationResearchpeer-review

  35. 2014
  36. Published

    Letter: the effects of rifaximin in hepatic encephalopathy--authors' reply

    Kimer, N., Krag, A. & Gluud, L. L., Oct 2014, In: Alimentary Pharmacology and Therapeutics. 40, 7, p. 858-9 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  37. Published

    Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy

    Kimer, N., Krag, A., Møller, S., Bendtsen, F. & Gluud, L. L., Jul 2014, In: Alimentary Pharmacology and Therapeutics. 40, 2, p. 123-32 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published

    New vasoactive peptides in cirrhosis: Organ extraction and relation to the vasodilatory state

    Kimer, N., Goetze, J. P., Bendtsen, F. & Møller, S., 29 Jan 2014, In: European Journal of Clinical Investigation. p. 441-52 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy

    Kimer, N., Krag, A. & Gluud, L. L., 2014, In: Patient Preference and Adherence. 8, p. 331-8 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. 2013
  41. Published

    The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy

    Lauridsen, M. M., Thiele, M., Kimer, N. & Vilstrup, H., Jun 2013, In: Metabolic Brain Disease. 28, 2, p. 231-4 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. 2012
  43. Published
  44. Published

    Letter: vaptans for the treatment of hyponatraemia and ascites in patients with cirrhosis - author's reply

    Gluud, L. L., Krag, A. A. & Kimer, N., 2012, In: Alimentary Pharmacology and Therapeutics. 36, p. 1104 1 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  45. Published

ID: 36753854